Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

8  +0.06 (+0.76%)

Fundamental Rating

6

SVS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. An interesting combination arises when we look at growth and value: SVS is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SVS had positive earnings in the past year.
SVS had a positive operating cash flow in the past year.
SVS had positive earnings in each of the past 5 years.
SVS had a positive operating cash flow in each of the past 5 years.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

With a Return On Assets value of 3.44%, SVS perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
SVS has a better Return On Equity (9.25%) than 70.18% of its industry peers.
SVS's Return On Invested Capital of 7.57% is fine compared to the rest of the industry. SVS outperforms 73.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SVS is below the industry average of 8.22%.
The 3 year average ROIC (6.10%) for SVS is below the current ROIC(7.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

SVS has a Profit Margin (4.49%) which is in line with its industry peers.
In the last couple of years the Profit Margin of SVS has grown nicely.
With a Operating Margin value of 8.07%, SVS perfoms like the industry average, outperforming 49.12% of the companies in the same industry.
In the last couple of years the Operating Margin of SVS has grown nicely.
Looking at the Gross Margin, with a value of 25.79%, SVS is doing worse than 84.21% of the companies in the same industry.
SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for SVS has been reduced compared to 1 year ago.
Compared to 5 years ago, SVS has less shares outstanding
SVS has a worse debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

SVS has an Altman-Z score of 1.86. This is not the best score and indicates that SVS is in the grey zone with still only limited risk for bankruptcy at the moment.
SVS has a Altman-Z score (1.86) which is comparable to the rest of the industry.
SVS has a debt to FCF ratio of 1707.47. This is a negative value and a sign of low solvency as SVS would need 1707.47 years to pay back of all of its debts.
With a Debt to FCF ratio value of 1707.47, SVS perfoms like the industry average, outperforming 43.86% of the companies in the same industry.
SVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating SVS is somewhat dependend on debt financing.
SVS's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. SVS is outperformed by 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Altman-Z 1.86
ROIC/WACC1.1
WACC6.9%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
SVS has a Current ratio of 1.96. This is comparable to the rest of the industry: SVS outperforms 57.89% of its industry peers.
A Quick Ratio of 1.42 indicates that SVS should not have too much problems paying its short term obligations.
SVS's Quick ratio of 1.42 is fine compared to the rest of the industry. SVS outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.52% over the past year.
The Earnings Per Share has been growing by 22.81% on average over the past years. This is a very strong growth
The Revenue has grown by 12.19% in the past year. This is quite good.
The Revenue has been growing by 11.34% on average over the past years. This is quite good.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.90% on average per year.
The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.84, the valuation of SVS can be described as very cheap.
Based on the Price/Earnings ratio, SVS is valued cheaper than 98.25% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.46, SVS is valued rather cheaply.
SVS is valuated cheaply with a Price/Forward Earnings ratio of 6.09.
SVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. SVS is cheaper than 96.49% of the companies in the same industry.
SVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 7.84
Fwd PE 6.09
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 91.23% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as SVS.
Industry RankSector Rank
P/FCF 1204.3
EV/EBITDA 3.56
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SVS's earnings are expected to grow with 16.90% in the coming years.
PEG (NY)0.38
PEG (5Y)0.34
EPS Next 2Y22.24%
EPS Next 3Y16.9%

More info and screens

4

5. Dividend

5.1 Amount

SVS has a Yearly Dividend Yield of 3.10%.
Compared to an average industry Dividend Yield of 2.07, SVS pays a better dividend. On top of this SVS pays more dividend than 89.47% of the companies listed in the same industry.
SVS's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.1%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y22.24%
EPS Next 3Y16.9%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

More info and screens

SVAS BIOSANA SPA

BIT:SVS (7/11/2025, 7:00:00 PM)

8

+0.06 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.80M
Analysts80
Price Target13.87 (73.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.68%
PT rev (3m)9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 7.84
Fwd PE 6.09
P/S 0.37
P/FCF 1204.3
P/OCF 7.32
P/B 0.76
P/tB 0.95
EV/EBITDA 3.56
EPS(TTM)1.02
EY12.75%
EPS(NY)1.31
Fwd EY16.41%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.67%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC6.9%
ROIC/WACC1.1
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%